Kamada (KMDA) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free KMDA Stock Alerts $5.36 -0.01 (-0.19%) (As of 01:03 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | stocknews.com3 Pharma Stocks With May PotentialMay 13, 2024 | americanbankingnews.comQ4 2024 EPS Estimates for Kamada Ltd. Raised by HC Wainwright (NASDAQ:KMDA)May 13, 2024 | americanbankingnews.comKamada (NASDAQ:KMDA) Rating Reiterated by HC WainwrightMay 11, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Kamada Ltd. (NASDAQ:KMDA) Cut by AnalystMay 10, 2024 | marketbeat.comKamada Ltd. Forecasted to Post Q2 2024 Earnings of $0.05 Per Share (NASDAQ:KMDA)Kamada Ltd. (NASDAQ:KMDA - Free Report) - Stock analysts at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for shares of Kamada in a note issued to investors on Thursday, May 9th. HC Wainwright analyst A. Fein now forecasts that the biotechnology company will post earninMay 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kamada on Accelerated Trial Prospects and Strong Financial PerformanceMay 9, 2024 | finance.yahoo.comKamada Ltd. (NASDAQ:KMDA) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Kamada (NASDAQ:KMDA)HC Wainwright reiterated a "buy" rating and set a $11.00 price objective on shares of Kamada in a research note on Thursday.May 8, 2024 | investorplace.comKMDA Stock Earnings: Kamada Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | globenewswire.comKamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial GuidanceMay 8, 2024 | markets.businessinsider.comKamada earnings: here's what Wall Street expectsMay 2, 2024 | marketbeat.comKamada (KMDA) Scheduled to Post Earnings on WednesdayKamada (NASDAQ:KMDA) will be releasing earnings before the market opens on Wednesday, May 8, Zacks reports.May 1, 2024 | globenewswire.comKamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024April 23, 2024 | marketbeat.comKamada (NASDAQ:KMDA) Share Price Passes Below Two Hundred Day Moving Average of $5.46Kamada (NASDAQ:KMDA) Shares Cross Below 200 Day Moving Average of $5.46April 19, 2024 | msn.comKamada Ekadashi 2024: When is Kamada Ekadashi? Know date, Ekadashi tithi, shubh muhurat, Parana time and significanceApril 19, 2024 | msn.comKamada Ekadashi 2024: Know significance, spiritual benefits, rituals and moreMarch 19, 2024 | finance.yahoo.comKMDA Aug 2024 10.000 callMarch 19, 2024 | finance.yahoo.comKMDA May 2024 5.000 callMarch 18, 2024 | marketbeat.comShort Interest in Kamada Ltd. (NASDAQ:KMDA) Increases By 10.0%Kamada Ltd. (NASDAQ:KMDA - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 51,900 shares, an increase of 10.0% from the February 14th total of 47,200 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average daily volume of 69,000 shares, the short-interest ratio is presently 0.8 days.March 16, 2024 | finance.yahoo.comKMDA Apr 2024 10.000 callMarch 15, 2024 | marketbeat.comFY2024 EPS Estimates for Kamada Ltd. Reduced by Analyst (NASDAQ:KMDA)Kamada Ltd. (NASDAQ:KMDA - Free Report) - Stock analysts at Zacks Small Cap cut their FY2024 EPS estimates for Kamada in a research note issued to investors on Wednesday, March 13th. Zacks Small Cap analyst D. Bautz now forecasts that the biotechnology company will post earnings of $0.18 per sharMarch 13, 2024 | finance.yahoo.comKMDA: Double Digit Growth Anticipated in 2024 with $158 Million in Expected Revenues and $28 Million in Expected Adjusted EBITDA…March 8, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Kamada Ltd.'s Q1 2024 Earnings (NASDAQ:KMDA)Kamada Ltd. (NASDAQ:KMDA - Free Report) - Stock analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for shares of Kamada in a research report issued to clients and investors on Thursday, March 7th. HC Wainwright analyst A. Fein anticipates that the biotechnology company wiMarch 7, 2024 | benzinga.comPreview: Kamada's EarningsMarch 7, 2024 | markets.businessinsider.comStrategic Partnerships and Product Portfolio Expansion Poise Kamada for Robust GrowthMarch 7, 2024 | finance.yahoo.comKamada Ltd. (NASDAQ:KMDA) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Kamada (NASDAQ:KMDA)HC Wainwright reaffirmed a "buy" rating and issued a $11.00 price target on shares of Kamada in a report on Thursday.March 6, 2024 | msn.comFootball: Kubo, Kamada exit Champions League as Sociedad, Lazio loseMarch 6, 2024 | washingtonpost.comKamada: Q4 Earnings SnapshotMarch 6, 2024 | investorplace.comKMDA Stock Earnings: Kamada Beats EPS, Misses Revenue for Q4 2023March 6, 2024 | marketbeat.comKamada (NASDAQ:KMDA) Releases Earnings Results, Beats Estimates By $0.05 EPSKamada (NASDAQ:KMDA - Get Free Report) issued its quarterly earnings data on Wednesday. The biotechnology company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.05 by $0.05. Kamada had a return on equity of 5.93% and a net margin of 4.07%. During the same period last year, the company earned $0.11 EPS.March 6, 2024 | globenewswire.comKamada Issues 2024 CEO Letter to ShareholdersMarch 6, 2024 | globenewswire.comKamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and ProfitabilityFebruary 28, 2024 | globenewswire.comKamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024February 22, 2024 | benzinga.comKamada Stock (NASDAQ:KMDA) Dividends: History, Yield and DatesFebruary 16, 2024 | marketbeat.comKamada Ltd. (NASDAQ:KMDA) Short Interest Down 6.7% in JanuaryKamada Ltd. (NASDAQ:KMDA - Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 45,700 shares, a drop of 6.7% from the January 15th total of 49,000 shares. Currently, 0.2% of the company's stock are sold short. Based on an average trading volume of 65,400 shares, the days-to-cover ratio is presently 0.7 days.February 8, 2024 | wsj.comKamada Ltd.January 31, 2024 | stocknews.com3 Pharma Gems Driving Profits NowJanuary 14, 2024 | marketbeat.comKamada Ltd. (NASDAQ:KMDA) Short Interest UpdateKamada Ltd. (NASDAQ:KMDA - Get Free Report) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 72,600 shares, a growth of 16.5% from the December 15th total of 62,300 shares. Based on an average daily trading volume, of 67,300 shares, the days-to-cover ratio is presently 1.1 days. Approximately 0.2% of the shares of the stock are sold short.January 12, 2024 | stocknews.comWill These 3 Pharma Stocks Become Gainers in 2024?January 4, 2024 | marketbeat.comKamada (NASDAQ:KMDA) Upgraded at StockNews.comStockNews.com raised shares of Kamada from a "hold" rating to a "buy" rating in a research note on Thursday.December 18, 2023 | marketbeat.comKamada (NASDAQ:KMDA) Lifted to Buy at StockNews.comStockNews.com raised Kamada from a "hold" rating to a "buy" rating in a research report on Monday.December 8, 2023 | seekingalpha.comKamada: Kedrion Deal Locks In GrowthDecember 7, 2023 | msn.comKMDA: Amendment and Extension of Kedrab® U.S. Distribution Agreement to Generate at Least $180 Million Over First Four Years…December 7, 2023 | finance.yahoo.comKEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®December 7, 2023 | marketwatch.comKamada Shares Hit 52-Week High After Extending Agreement With KedrionNovember 15, 2023 | finance.yahoo.comKMDA: $37.9 Million in 3Q23 Revenues; Closes $60 Million Private Placement with FIMI Opportunity Funds…November 14, 2023 | benzinga.comKamada Stock (NASDAQ:KMDA) Earnings Dates and Earning CallsNovember 13, 2023 | msn.comKamada beats Q3 top and bottom line estimates; reaffirms FY23 outlookNovember 13, 2023 | finance.yahoo.comKamada: Q3 Earnings Snapshot Get Kamada News Delivered to You Automatically Sign up to receive the latest news and ratings for KMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… KMDA Media Mentions By Week KMDA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KMDA News Sentiment▼0.810.42▲Average Medical News Sentiment KMDA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KMDA Articles This Week▼31▲KMDA Articles Average Week Get Kamada News Delivered to You Automatically Sign up to receive the latest news and ratings for KMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Nkarta News Nektar Therapeutics News Erasca News ADC Therapeutics News Atai Life Sciences News Mersana Therapeutics News Verastem News Atea Pharmaceuticals News Precigen News Nanobiotix News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KMDA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kamada Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
